© 2021 MJH Life Sciences and HCPLive - Clinical news for connected physicians. All rights reserved.
© 2021 MJH Life Sciences™ and HCPLive - Clinical news for connected physicians. All rights reserved.
March 04, 2021
The study underscores the importance of interpreting patient-reported disease severity scores in the context of mental health factors.
February 17, 2021
Apremilast has been prescribed to more than 250,000 patients with plaque psoriasis or psoriatic arthritis since it was approved in 2014.
February 05, 2021
Two studies demonstrated that the IL-17A and IL-17F inhibitor can lead to superior levels of skin of clearance in adult patients compared with ustekinumab or placebo.
January 31, 2021
Todd Schlesinger, MD, talks new therapies on the horizon and those that have already proven efficacious.
December 16, 2020
The FDA approvals of biologics for atopic dermatitis and psoriasis have ushered in a new era for the once-stagnant field of pediatric dermatology.
December 03, 2020
There is a gap between the efficacy of biologics in trials and the real-world setting.
December 01, 2020
Strict avoidance of systemic corticosteroids among patients with psoriasis may be unnecessary.
November 23, 2020
November 16, 2020
November 10, 2020
Favorable phase 2 results with the TYK2 inhibitor for psoriatic arthritis at ACR 2020 coincided with announced positive phase 3 trial results for psoriasis.